Titre:home - inoviem scientific
La description :we are dedicated to the development of technologies aiming at improving lead compound selection and decreasing attrition rates during drug development by better predicting drug effects and safety....
Server:nginx...
X-Powered-By:PHP/5.6.37, PleskLin
L'adresse IP principale: 37.187.171.39,Votre serveur France,Roubaix ISP:OVH SAS TLD:com Code postal:fr
Ce rapport est mis à jour en 03-Aug-2018
Created Date: | 2012-05-30 |
Changed Date: | 2017-05-15 |
Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations. Notre service GeoIP a trouvé l'hôte inoviem.com.Actuellement, hébergé dans France et son fournisseur de services est OVH SAS .
Latitude: | 50.69421005249 |
Longitude: | 3.1745600700378 |
Pays: | France (fr) |
Ville: | Roubaix |
Région: | Nord-Pas-de-Calais |
ISP: | OVH SAS |
domaine | Titre |
---|---|
inoviem.com | home - inoviem scientific |
patricebacchin.fr | p. bacchin scientific home page - home |
scientificbazaar.com | scientific equipments, science lab manufacturers, scientific instruments exporte |
shieldscientific.com | shield scientific manufacturer of latex and nitrile gloves : shield scientific |
sepsci.co.za | separation scientific | |
thescientifictradingmachine.com | the scientific trading machine |
scientifictradingmachines.com | scientific trading machine |
fishersci.fr | fisher scientific: lab equipment and supplies |
cnrs.com | The National Center for Scientific Research Welcome |
cirs-tm.org | international center for scientific research - cirs |
iussp.org | what's new | international union for the scientific study of population |
ripplerecruit.co.uk | ripple recruit | it and scientific recruitment in reading |
raweb.inria.fr | inria - scientific activity reports index |
experiment.com | experiment | crowdfunding platform for scientific research |
arcjournals.org | open access publications | best scientific journals online |
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé nginx contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
Content-Length: | 8855 |
X-Powered-By: | PHP/5.6.37, PleskLin |
Accept-Ranges: | none |
Content-Encoding: | gzip |
Vary: | Accept-Encoding,User-Agent |
Server: | nginx |
Connection: | keep-alive |
Link: | |
Cache-Control: | max-age=0, no-cache, s-maxage=10 |
Date: | Fri, 03 Aug 2018 03:45:43 GMT |
Content-Type: | text/html; charset=UTF-8 |
X-Mod-Pagespeed: | 1.13.35.2-0 |
soa: | ns347920.ip-37-187-171.eu. server.adeliom.com. 2018060703 10800 3600 604800 10800 |
ns: | ns347920.ip-37-187-171.eu. sdns2.ovh.net. |
ipv4: | IP:37.187.171.39 ASN:16276 OWNER:OVH, FR Country:FR |
ipv6: | 2001:41d0:d:a27:://16276//OVH, FR//FR |
txt: | "v=spf1 +a +mx ip4:46.31.43.33 ip4:46.31.43.38 include:_spf.google.com ~all" |
mx: | MX preference = 20, mail exchanger = secmx02.new-web.fr. MX preference = 30, mail exchanger = exchange.new-web.fr. MX preference = 10, mail exchanger = secmx01.new-web.fr. |
home about us about us who we are management team scientific board supervisory board & investors values isea services services preclinical and drug discovery patient stratification biomarkers clinical development technologies technologies npot® pims® complementary technologies partnering references news contact us home about us who we are management team scientific board supervisory board & investors values isea services preclinical and drug discovery patient stratification biomarkers clinical development technologies npot® pims® complementary technologies partnering references news tel.: +33 (0)9 72 56 94 99 from preclinical to clinical a leading explorer of drug-target interaction « exploring a therapeutic target under its physiological conditions yields crucial information for developing highly effective molecules, while at the same time significantly reducing their side effects. our proprietary technologies enable us to achieve this feat. » dr pierre eftekhari, president inoviem scientific missions we are dedicated to the development of technologies aiming at improving lead compound selection and decreasing attrition rates during drug development by better predicting drug effects and toxicity. learn more our clients pharma companies can use these technologies for lead compound selection enabling innovative, efficient and fast drug development. our customers are any public or private organisations involved in the discovery and development of innovative drugs. learn more npot® technology elucidates the molecular moa of evodiamine’s antiartherosclerotic activity learn more khondrion in collaboration with inoviem scientific publishes kh176’s target and mode of action learn more dr jasper de boer’s group publishes the targets identified with npot® learn more how to contact us inoviem scientific sas bioparc 3 850, boulevard sébastien brant f-67400 illkirch-graffenstaden tel.: +33 (0)9 72 56 94 99 sitemaps home about us news partnering references services technologies information legal information and cookies social networks © 2018 inoviem scientific - all rights reserved. we use cookies to ensure that we give you the best experience on our website. if you continue to use this site we will assume that you are happy with it. ok
http://www.inoviem.com/references/
http://www.inoviem.com/about-us/management-team/
http://www.inoviem.com/about-us/scientific-board/
http://www.inoviem.com/about-us/values/
http://www.inoviem.com/news/
http://www.inoviem.com/services/drug-discovery-and-preclinical/
http://www.inoviem.com/khondrion-in-collaboration-with-inoviem-scientific-publishes-kh176s-target-and-mode-of-action/
http://www.inoviem.com/about-us/isea/
http://www.inoviem.com/technologies/
http://www.inoviem.com/about-us/who-we-are/
http://www.inoviem.com/services/clinical-development/
http://www.inoviem.com/services/
http://www.inoviem.com/npot-technology-elucidates-the-molecular-moa-of-evodiamines-antiartherosclerotic-activity/
http://www.inoviem.com/services/patient-stratification/
http://www.inoviem.com/partnering/
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
Domain Name: INOVIEM.COM
Registry Domain ID: 1723929019_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.ovh.com
Registrar URL: http://www.ovh.com
Updated Date: 2017-05-15T12:44:25Z
Creation Date: 2012-05-30T17:12:11Z
Registry Expiry Date: 2018-05-30T17:12:11Z
Registrar: OVH
Registrar IANA ID: 433
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS347920.IP-37-187-171.EU
Name Server: SDNS2.OVH.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-30T04:22:47Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR OVH
SERVERS
SERVER com.whois-servers.net
ARGS domain =inoviem.com
PORT 43
TYPE domain
RegrInfo
DOMAIN
NAME inoviem.com
CHANGED 2017-05-15
CREATED 2012-05-30
STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
NSERVER
NS347920.IP-37-187-171.EU 37.187.171.39
SDNS2.OVH.NET 213.251.188.141
REGISTERED yes
La liste suivante vous montre les fautes d'orthographe possibles des internautes pour le site Web recherché.